Quick Takeaways
- Adele M. Gulfo has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,498,201.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Adele M. Gulfo
- Location
- Charlotte, NC
- Summary
- The estimated net worth of Adele M. Gulfo is at least $3,498,201 dollars as of 19 Mar 2026. Adele M. Gulfo is the Director of Enpro Inc. and owns shares of Enpro Inc. (NPO) stock worth about $2.33M. Adele M. Gulfo is the Director of Tyra Biosciences, Inc. and owns shares of Tyra Biosciences, Inc. (TYRA) stock worth about $670K. Adele M. Gulfo is the Director of NewAmsterdam Pharma Co N.V. and owns shares of NewAmsterdam Pharma Co N.V. (NAMS) stock worth about $500.5K.
- Signature
- Angela P. Winter, Attorney-in-Fact of Adele M. Gulfo
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Adele M. Gulfo and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Enpro Inc. ($2,327,733).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Adele M. Gulfo
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NPO | Enpro Inc. | Director | $2,327,733 | 18 Mar 2026 | ||
| TYRA | Tyra Biosciences, Inc. | Director | $670,011 | 29 Jan 2025 | ||
| NAMS, NAMSW | NewAmsterdam Pharma Co N.V. | Director | $500,457 | 07 Jan 2026 | ||
| MYOV | Myovant Sciences Ltd. | Director | 10 Mar 2023 |
Insider Transactions Reported by Adele M. Gulfo:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.